{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:53:32Z","timestamp":1740142412095,"version":"3.37.3"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011566","name":"Sidney Kimmel Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA006973"],"award-info":[{"award-number":["P30CA006973"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cll.2023.08.014","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T06:20:08Z","timestamp":1716963608000},"page":"355-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Pathology of Mature Lymphoid Malignancies"],"prefix":"10.1016","volume":"44","author":[{"given":"Alisha D.","family":"Ware","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelynn","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rena R.","family":"Xian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","key":"10.1016\/j.cll.2023.08.014_bib1"},{"issue":"2","key":"10.1016\/j.cll.2023.08.014_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5858\/2007-131-185-DOCIGR","article-title":"Detection of clonal IGH gene rearrangements: summary of molecular oncology surveys of the College of American Pathologists","volume":"131","author":"Nikiforova","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.cll.2023.08.014_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-020-0335-0","article-title":"CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma","volume":"10","author":"Xian","year":"2020","journal-title":"Blood Cancer J"},{"issue":"3","key":"10.1016\/j.cll.2023.08.014_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjh.15041","article-title":"The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion","volume":"180","author":"Zam\u00f2","year":"2018","journal-title":"Br J Haematol"},{"issue":"22","key":"10.1016\/j.cll.2023.08.014_bib5","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.cll.2023.08.014_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-019-0132-x","article-title":"Follicular lymphoma","volume":"5","author":"Carbone","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.cll.2023.08.014_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.56.1","article-title":"Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis","volume":"56","author":"Sugimoto","year":"2016","journal-title":"J\u00a0Clin Exp Hematop"},{"issue":"5\u20136","key":"10.1016\/j.cll.2023.08.014_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.seminoncol.2018.07.005","article-title":"New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs","volume":"45","author":"Devan","year":"2018","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1016\/j.cll.2023.08.014_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00428-019-02681-y","article-title":"Novel markers in pediatric-type follicular lymphoma","volume":"475","author":"Agostinelli","year":"2019","journal-title":"Virchows Arch"},{"issue":"18","key":"10.1016\/j.cll.2023.08.014_bib10","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood-2013-04-496893","article-title":"EZH2 mutations are frequent and represent an early event in follicular lymphoma","volume":"122","author":"B\u00f6d\u00f6r","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2023.08.014_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40265-020-01288-x","article-title":"Tazemetostat: first approval","volume":"80","author":"Hoy","year":"2020","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.cll.2023.08.014_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood-2015-12-682591","article-title":"Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations","volume":"128","author":"Louissaint","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cll.2023.08.014_bib13","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","article-title":"Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene","volume":"128","author":"Schmidt","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2023.08.014_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/imr.12755","article-title":"Germinal center-derived lymphomas: The darkest side of humoral immunity","volume":"288","author":"Mlynarczyk","year":"2019","journal-title":"Immunol Rev"},{"issue":"12","key":"10.1016\/j.cll.2023.08.014_bib15","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A\u00a0subset of t (11; 14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cll.2023.08.014_bib16","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.cll.2023.08.014_bib17","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1182\/blood-2009-03-212449","article-title":"Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior","volume":"114","author":"Forconi","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cll.2023.08.014_bib18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1200\/JCO.2015.63.5904","article-title":"Mantle Cell Lymphoma","volume":"34","author":"Cheah","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cll.2023.08.014_bib19","doi-asserted-by":"crossref","first-page":"103038","DOI":"10.1016\/j.critrevonc.2020.103038","article-title":"Mantle cell lymphoma","volume":"153","author":"Cortelazzo","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.cll.2023.08.014_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/hematology.2019000011","article-title":"Molecular profiling and management of mantle cell lymphoma","volume":"2019","author":"Ruan","year":"2019","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"12","key":"10.1016\/j.cll.2023.08.014_bib21","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood.2020005289","article-title":"Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes","volume":"136","author":"Nadeu","year":"2020","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.cll.2023.08.014_bib22","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood-2017-10-764373","article-title":"Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions","volume":"131","author":"Puente","year":"2018","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cll.2023.08.014_bib23","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/cncr.31328","article-title":"Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy","volume":"124","author":"Greenwell","year":"2018","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.cll.2023.08.014_bib24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PAS.0000000000000758","article-title":"Mantle Cell Lymphoma With MYC Rearrangement","volume":"41","author":"Hu","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.cll.2023.08.014_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/bjh.15108","article-title":"Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects","volume":"181","author":"Hershkovitz-Rokah","year":"2018","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.cll.2023.08.014_bib26","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ajh.25595","article-title":"Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment","volume":"94","author":"Hallek","year":"2019","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.cll.2023.08.014_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrc.2016.8","article-title":"The molecular pathogenesis of chronic lymphocytic leukaemia","volume":"16","author":"Fabbri","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.cll.2023.08.014_bib28","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/bjh.16102","article-title":"Molecular pathogenesis of chronic lymphocytic leukaemia","volume":"186","author":"Crassini","year":"2019","journal-title":"Br J Haematol"},{"issue":"7757","key":"10.1016\/j.cll.2023.08.014_bib29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-019-1198-z","article-title":"Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia","volume":"569","author":"Gaiti","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cll.2023.08.014_bib30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3324\/haematol.2012.070458","article-title":"Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"98","author":"Nguyen-Khac","year":"2013","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.cll.2023.08.014_bib31","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood-2017-01-765107","article-title":"Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations","volume":"130","author":"Durham","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cll.2023.08.014_bib32","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/s41379-018-0093-8","article-title":"Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience","volume":"31","author":"Angelova","year":"2018","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.cll.2023.08.014_bib33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/ajh.25653","article-title":"Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Maitre","year":"2019","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.cll.2023.08.014_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pathol.2019.09.009","article-title":"Lymphoplasmacytic lymphoma and Waldenstr\u00f6m macroglobulinaemia: clinicopathological features and differential diagnosis","volume":"52","author":"Wang","year":"2020","journal-title":"Pathology"},{"issue":"1\u20132","key":"10.1016\/j.cll.2023.08.014_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.beha.2016.09.004","article-title":"Molecular pathogenesis of splenic and nodal marginal zone lymphoma","volume":"30","author":"Spina","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"issue":"10","key":"10.1016\/j.cll.2023.08.014_bib36","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","author":"Spina","year":"2016","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.cll.2023.08.014_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.beha.2016.11.001","article-title":"Pathology of nodal marginal zone lymphomas","volume":"30","author":"Pileri","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"issue":"12","key":"10.1016\/j.cll.2023.08.014_bib38","article-title":"Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key Histomorphologic, Immunophenotypic, and Genetic Features","volume":"10","author":"Lauw","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"19","key":"10.1016\/j.cll.2023.08.014_bib39","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.2019001880","article-title":"The whole-genome landscape of Burkitt lymphoma subtypes","volume":"134","author":"Panea","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cll.2023.08.014_bib40","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","article-title":"The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma","volume":"133","author":"Wagener","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cll.2023.08.014_bib41","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2023.08.014_bib42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cll.2023.08.014_bib43","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2014.821","article-title":"High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type","volume":"150","author":"Pham-Ledard","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"15","key":"10.1016\/j.cll.2023.08.014_bib44","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.cll.2023.08.014_bib45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1200\/JCO.18.01583","article-title":"Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma","volume":"37","author":"Ennishi","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.cll.2023.08.014_bib46","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1182\/blood-2017-12-820605","article-title":"High-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology","volume":"131","author":"Scott","year":"2018","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cll.2023.08.014_bib47","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41379-018-0067-x","article-title":"MYC\/BCL2\/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC\/BCL2 and MYC\/BCL6 double hit lymphomas","volume":"31","author":"Huang","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2023.08.014_bib48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.anndiagpath.2018.09.014","article-title":"Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues","volume":"38","author":"Grimm","year":"2019","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"10.1016\/j.cll.2023.08.014_bib49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00428-015-1855-z","article-title":"Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4\/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia","volume":"468","author":"Quintanilla-Martinez","year":"2016","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.cll.2023.08.014_bib50","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cll.2023.08.014_bib51","doi-asserted-by":"crossref","first-page":"e0178416","DOI":"10.1371\/journal.pone.0178416","article-title":"Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature","volume":"12","author":"Jiang","year":"2017","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2023.08.014_bib52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41379-019-0385-7","article-title":"Navigating the cutaneous B-cell lymphomas: avoiding the rocky shoals","volume":"33","author":"Jaffe","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2023.08.014_bib53","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1100\/tsw.2011.59","article-title":"Plasmablastic lymphoma: a systematic review","volume":"11","author":"Castillo","year":"2011","journal-title":"ScientificWorldJournal"},{"issue":"64","key":"10.1016\/j.cll.2023.08.014_bib54","doi-asserted-by":"crossref","first-page":"107356","DOI":"10.18632\/oncotarget.22219","article-title":"MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma","volume":"8","author":"Ambrosio","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.cll.2023.08.014_bib55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.beha.2019.06.006","article-title":"T\u00a0cell large granular lymphocyte leukemia and chronic NK lymphocytosis","volume":"32","author":"Baril\u00e0","year":"2019","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1","key":"10.1016\/j.cll.2023.08.014_bib56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/PAS.0000000000000735","article-title":"EBV-negative Aggressive NK-cell Leukemia\/Lymphoma: Clinical, Pathologic, and Genetic Features","volume":"41","author":"Nicolae","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.cll.2023.08.014_bib57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/cr.2017.146","article-title":"Integrated genomic analysis identifies deregulated JAK\/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Res"},{"issue":"12","key":"10.1016\/j.cll.2023.08.014_bib58","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41408-017-0021-z","article-title":"Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes","volume":"7","author":"Tang","year":"2017","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.cll.2023.08.014_bib59","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41467-018-03987-2","article-title":"Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target","volume":"9","author":"Dufva","year":"2018","journal-title":"Nat Commun"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2023.08.014_bib60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/ijlh.12817","article-title":"The 2017 WHO update on mature T- and natural killer (NK) cell neoplasms","volume":"40","author":"Matutes","year":"2018","journal-title":"Int J Lab Hematol"},{"issue":"14","key":"10.1016\/j.cll.2023.08.014_bib61","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.2019000402","article-title":"Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia","volume":"134","author":"Staber","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cll.2023.08.014_bib62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cll.2023.08.014_bib63","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/cas.13303","article-title":"Genetic alterations in adult T-cell leukemia\/lymphoma","volume":"108","author":"Kogure","year":"2017","journal-title":"Cancer Sci"},{"issue":"8","key":"10.1016\/j.cll.2023.08.014_bib64","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JOP.2017.021907","article-title":"Adult T-Cell Leukemia\/Lymphoma","volume":"13","author":"Mehta-Shah","year":"2017","journal-title":"J\u00a0Oncol Pract"},{"issue":"15","key":"10.1016\/j.cll.2023.08.014_bib65","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cll.2023.08.014_bib66","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood-2016-09-692541","article-title":"Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma","volume":"129","author":"Lunning","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.cll.2023.08.014_bib67","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-319-99716-2_2","article-title":"Molecular and Genomic Landscape of Peripheral T-Cell Lymphoma","volume":"176","author":"Iqbal","year":"2019","journal-title":"Cancer Treat Res"},{"issue":"1","key":"10.1016\/j.cll.2023.08.014_bib68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3322\/caac.21589","article-title":"The rapidly changing landscape in mature T-cell lymphoma (MTCL) biology and management","volume":"70","author":"Marchi","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.cll.2023.08.014_bib69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2016.112","article-title":"The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia","volume":"17","author":"Sperling","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.cll.2023.08.014_bib70","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronn\u00e9","year":"2012","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271223000914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271223000914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T13:20:31Z","timestamp":1717248031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271223000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0272271223000914"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2023.08.014","relation":{},"ISSN":["0272-2712"],"issn-type":[{"type":"print","value":"0272-2712"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Pathology of Mature Lymphoid Malignancies","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2023.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}